CDSCO to Reject Long-Pending SUGAM Applications After 30 Days for Non-Response to Queries
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has announced that it will dispose of and reject long-pending applications submitted through the SUGAM portal where applicants have failed to respond to queries raised during the evaluation process, even after repeated reminders.
The decision has been conveyed through a public notice dated 16 January 2026, issued by the national drug regulator under the Directorate General of Health Services (DGHS), Ministry of Health and Family Welfare.
Applicants who fail to respond to the pending queries through email and the SUGAM portal even after issuance of the three reminders are subsequently issued a fourth and final communication, informing them that their application stands rejected, with the fee amount forfeited, in accordance with the applicable provisions
Importantly, the regulator has now set a final timeline for the disposal of such applications. The CDSCO informed all stakeholders that applications that have remained pending for more than two years and have already undergone the three-reminder process shall be rejected after a period of 30 days from the date of issuance of the public notice.
A final rejection communication will be issued to the concerned applicants once this 30-day period lapses.
In its concluding advisory, the CDSCO urged all stakeholders to ensure that all pending queries are addressed within the stipulated time period, cautioning that failure to do so would result in rejection of applications and forfeiture of fees.
To view the official notice, click the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.